<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1810234353
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        LIPOPLUS 20 % Emulsion For Infusion
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TRIGLYCERIDES MEDIUM CHAIN,SOYA OIL,OMEGA-3-ACID ETHYL ESTERS
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100,80,20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        g
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Emulsion for infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        83.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="B. BRAUN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            B. BRAUN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 971]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Medical Supplies And Services Co Ltd (Mediserv)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            B. BRAUN
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        NA
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Lipoplus 200 mg/ml is an emulsion of oils in water. The oils contained in Lipoplus 200 mg/ml provide energy and contain essential fatty acids that are needed for your body to grow or recover.<br />Lipoplus 200 mg/ml is used to provide fat to patients needing to be fed by an intravenous drip, because they are unable to eat food normally or the normal intake is not enough.<br />Lipoplus is indicated in adults, preterm and term neonates, infants and toddlers, children and adolescents.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Lipoplus 200 mg/ml must NOT be used</strong><br />if one or more of the following conditions are present:<br />● if you are allergic to egg, fish, peanut, or soya-bean protein or any of the other ingredients of this medicine (listed in section 6).<br />● abnormally high blood fat level (severe hyperlipidaemia characterized by hypertriglyceridaemia)<br />● conditions where the blood does not clot properly (severe coagulopathy)<br />● impaired bile flow (intrahepatic cholestasis)<br />● severe liver failure (severe hepatic insufficiency)<br />● severe kidney failure (severe renal insufficiency) without access to treatment with an artificial kidney (haemofiltration or dialysis)<br />● blocking of blood vessels by blood clots or fat (acute thromboembolic events, fat embolism)<br />● abnormally high level of acidic substances in the blood (acidosis)</p><p><strong>Patients must generally not receive artificial nutrition via intravenous drip (parenteral nutrition)</strong><br />if one or more of the following conditions are present:<br />● life-threatening blood circulation problems such as those that can occur if you are in a state of collapse or shock<br />● acute phase of heart attack (cardiac infarction) or stroke<br />● unstable metabolism, for example because of diabetes mellitus, infections involving the whole body (severe sepsis), or coma of unknown origin<br />● insufficient supply of oxygen to tissues<br />● disturbances of your body salt composition<br />● fluid deficit or excess water in the body<br />● water in the lungs (acute pulmonary oedema)<br />● severe heart failure (decompensated cardiac insufficiency)</p><p><strong>Warnings and precautions</strong><br />Talk to your doctor before you are given Lipoplus 200 mg/ml.</p><p><strong>Monitoring</strong><br /> During infusion, the amount of fat (serum triglycerides) in your blood should be monitored by your doctor. If your blood fat values rises too high, your doctor may reduce the infusion speed or stop the infusion.</p><p> While you receive this solution, your doctor should check your levels of fluids, blood salts and the acidbase balance. Your liver and kidney function and your blood clotting function should be monitored and blood cell counts should be performed.</p><p> If you show signs of an allergic reaction &ndash; such as fever, shivering, rash, or breathing problems &ndash; when you receive this medicine, the infusion should be stopped immediately by your doctor.</p><p><strong>Additional measures</strong></p><p> Before you receive this medicine any existing disorders of your body&rsquo;s fluid and salt content as well as disturbances of your acid-base balance will be corrected by your doctor.</p><p> In addition to Lipoplus 200 mg/ml you may receive a carbohydrate solution and an amino acid solution to prevent metabolic conditions where your blood becomes acidic (metabolic acidosis).</p><p> To make your intravenous feeding complete, you may also receive carbohydrate solutions and amino acid solutions. The nursing staff may also take measures to ensure that your body&rsquo;s fluid, electrolyte, vitamin and trace element requirements are met.</p><p><strong>Elderly patients</strong><br />In some conditions your ability to use fat correctly may be impaired. Your doctor will keep in mind that some of these conditions are frequently associated with advanced age, e.g. impaired heart or kidney function.</p><p><strong>Patients with heart or kidney problems</strong><br />If you have heart or kidney problems, your doctor will be especially careful when giving you this medicine.</p><p><strong>Patients with impaired lipid metabolism</strong></p><p>In some conditions your ability to use fat correctly may be impaired and your blood fat values may be too high. Therefore, it is important that your doctor knows:<br />● if you have diabetes mellitus<br />● if you have an inflammation of the pancreas (pancreatitis)<br />● if you have impaired liver or kidney function (renal insufficiency, impaired hepatic function)<br />● if you have a reduced activity of the thyroid gland (hypothyroidism)<br />● if you have blood poisoning (sepsis)<br />● if you have a condition where you may have a combination of 3 or more of the following: an increase in fat around your abdomen, a decrease in &ldquo;good cholesterol&rdquo; (HDL-C), an increase in your blood fat, high blood pressure and an increase in your blood sugar (metabolic syndrome)</p><p>If your ability to use fat correctly is impaired, your doctor should monitor your blood fat (serum triglyceride) levels very closely.</p><p><strong>Children and adolescents</strong><br />In infants at risk of jaundice the blood fat (serum triglyceride) and bilirubin levels should be monitored by your doctor. It may become necessary for your doctor to adjust the daily fat doses.<br />During infusion this solution should be protected from the light of a phototherapy to decrease the formation of potentially harmful substances (triglyceride hydroperoxides).</p><p><strong>Other medicines and Lipoplus 200 mg/ml</strong><br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Lipoplus 200 mg/ml may interact with some other medicines. Tell your doctor if you are taking or receiving certain medicines that prevent undesirable blood clotting, namely<br />● heparin<br />● coumarin products, for example warfarin.<br />It may be necessary to check the clotting of your blood by taking regular blood samples.</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before you are given this medicine.</p><p><strong>Pregnancy</strong><br />If you are pregnant you will receive this medicine only if the doctor considers it absolutely necessary for your<br />recovery. There is no data about the use of Lipoplus 200 mg/ml in pregnant women.</p><p><strong>Breast-feeding</strong><br />Breast-feeding is not recommended for mothers on parenteral nutrition.</p><p><strong>Driving and using machines</strong><br />You will receive this medicine in a controlled setting, i.e. a hospital or under any other kind of medical supervision, which normally excludes driving or using machines.</p><p><strong>Lipoplus 200 mg/ml contains sodium</strong><br />Lipoplus 200 mg/ml contains 2.6 mmol/l sodium. This should be taken into consideration by patients on a controlled sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dosage</strong><br />Your doctor will decide how much of this medicine you need and for how long you will require treatment with this medicine.<br />The daily doses will be adjusted to your needs, your age and your body weight. The doses are normally calculated on a &quot;gram of fat per kg body weight&quot;&nbsp;basis. Care will be taken that the doses and infusion rates used are correct for you, so your body&#39;s capacity to use the infused fat will not be exceeded.</p><p><strong>How is Lipoplus 200 mg/ml given?</strong><br />Lipoplus 200 mg/ml will be given by an intravenous drip as part of a feeding programme. For this purpose a tube (catheter) will be inserted into a vein, through which the fat emulsion can either be given separately or<br />together with other fluids.</p><p><strong>If you received more Lipoplus 200 mg/ml than you should</strong><br />If you have received too much Lipoplus 200 mg/ml you may get abnormally high blood fat levels (hyperlipidaemia), your blood may become too acidic (metabolic acidosis) or you may suffer from a so-called &quot;fat overload syndrome&quot;. For symptoms of the fat overload syndrome please see section 4 &quot;Possible side effects&quot;.</p><p>If you have received too much Lipoplus 200 mg/ml, the infusion will be stopped immediately. The infusion will not be started again until you have recovered. It may be necessary for your doctor to adjust the daily fat doses. Your doctor will decide on any additional treatment.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>The following side effects may be serious. If any of the following side effects occur, contact your doctor immediately, they will stop giving you this medicine:</strong><br /><strong>Very rare: may affect up to 1 in 10,000 people</strong><br />- allergic reactions, for example skin reactions, shortness of breath, swelling of the lips, mouth and throat, difficulty breathing<br />- breathing problems (dyspnoea)<br />- bluish skin (cyanosis)</p><p><strong>Other side effects include</strong><br /><strong>Very rare: may affect up to 1 in 10,000 people</strong><br />- fat overload syndrome (see &quot;Fat overload syndrome&quot;&nbsp;below)<br />- increased tendency of your blood to clot (hypercoagulation)<br />- abnormally high blood fat levels (hyperlipidaemia)<br />- abnormally high blood sugar levels (hyperglycaemia)<br />- high levels of acidic substances in your blood (metabolic acidosis)<br />- decrease or increase in blood pressure<br />- drowsiness<br />- feeling sick, vomiting, loss of appetite<br />- headache<br />- flushing<br />- reddening of the skin (erythema)<br />- fever<br />- sweating<br />- feeling cold, chills<br /><strong>Rare: may affect up to 1 in 1,000 people</strong><br />- pain in the back, bones, chest and lumbar region<br /><strong>Not known: frequency cannot be estimated from the available data</strong><br />- impaired bile flow (cholestasis)<br />- reduction of white blood cell count (leucopenia)<br />- reduction of blood platelet count (thrombocytopenia)</p><p>If you get any of these side effects, the infusion will be stopped.</p><p><strong>Fat overload syndrome:</strong><br />You might suffer from a &quot;fat overload syndrome&quot;&nbsp;if you have received too much Lipoplus 200 mg/ml or when your body has problems using fat. Your body&#39;s ability to use fat might be influenced by a sudden change in your condition (due to renal problems or an infection). The symptoms are usually reversible if the infusion is<br />stopped. A fat overload syndrome is characterised by the following symptoms:<br />- high blood fat levels (hyperlipidaemia)<br />- fever<br />- deposition of fat in the liver or other organs (fat infiltration)<br />- enlargement of the liver (hepatomegaly), which may sometimes be accompanied by jaundice (icterus)<br />- enlargement of the spleen (splenomegaly)<br />- reduction of red blood cell count (anaemia)<br />- reduction of white blood cell count (leucopenia)<br />- reduction of blood platelet count (thrombocytopenia)<br />- disorder of blood clotting (coagulation disorder)<br />- rupture of blood cells (haemolysis)<br />- increase in immature red blood cells (reticulocytosis)<br />- abnormal liver function tests<br />- loss of consciousness (coma)</p><p><strong>Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.<br />By reporting side effects you can help provide more information on the safety of this medicine.</strong><br />&nbsp;</p><p><strong>Contact Information<br />Vigilance and Crisis management Executive Directorate<br />Saudi Arabia<br />Fax: 011 2057662<br />Email: npc.drug@sfda.gov.sa</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the label and the outer carton. The expiry date refers to the last day of that month.</p><p>After first opening Lipoplus 200 mg/ml should be used immediately.</p><p>Do not store above 25 <sup>o</sup>C.<br />Keep the container in the outer carton in order to protect from light.<br />Do not freeze. Products that have been frozen must be discarded.</p><p>Do not use this medicine if you notice:<br />- large oil drops in the emulsion or two separate layers of fluid<br />- discoloration<br />- damage of the container or the closure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substances in 1000 ml of Lipoplus 200 mg/ml are:<br />Medium-chain triglycerides 100.0 g<br />Soya-bean oil, refined 80.0 g<br />Omega-3-acid triglycerides 20.0 g</p><p>This gives the following content of essential fatty acids per litre:<br />Linoleic acid (omega-6) 38.4 - 46.4 g<br />Alpha-linolenic acid (omega-3) 4.0 - 8.8 g<br />Eicosapentaenoic acid and<br />docosahexaenoic acid (omega-3) 8.6 - 17.2 g</p><p>200 mg/ml (20%) correspond to total content of triglycerides.<br />Energy [kJ/l (kcal/l)] 7990 (1910)<br />Osmolality [mOsm/kg], approximately 410<br />Acidity or alkalinity (titration to pH 7.4) [mmol/l NaOH or HCl] &lt; 0.5<br />pH 6.5 - 8.5</p><p>- The other ingredients are glycerol, egg lecithin, all rac-a-tocopherol, ascorbyl palmitate, sodium oleate, sodium hydroxide (for pH adjustment) and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Lipoplus 200 mg/ml is a milky-white, sterile oil-in-water emulsion for infusion (for administration by a venous drip).

It is supplied in glass bottles with rubber stoppers, pack sizes:
10 x 100 ml, 1 x 250 ml, 10 x 250 ml, 1 x 500 ml, 10 x 500 ml, 1 x 1000 ml, 6 x 1000 ml

Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>B. Braun Melsungen AG<br />Carl-Braun-Str.&nbsp;1<br />34212 Melsungen, Germany</p><p>Postal address<br />34209 Melsungen, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                2016-03-10
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ليبوبلس 200&nbsp;مجم/مل هو مستحلب من الزيوت في الماء. تمد الزيوت الموجودة في ليبوبلس 200&nbsp;مجم/مل بالطاقة وتحتوي على الأحماض الدهنية الأساسية الضرورية التي يحتاجها جسمك لينمو ويسترد عافيته.</p><p dir="RTL">يُستخدم ليبوبلس 200&nbsp;مجم/مل لتوفير الدهون للمرضى الذين هم في حاجة إلى أن تتم تغذيتهم من خلال التقطير الوريدي، لأنهم غير قادرين على تناول الطعام بشكل طبيعي أو أن مقدار المأخوذ الغذائي الطبيعي غير كاف.</p><p dir="RTL">يُستخدم ليبوبلس للمرضى البالغين، ولحديثي الولادة المبتسرين والذين أتموا فترة الحمل، والرضع والأطفال حديثي المشي، والأطفال والمراهقين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عدم استخدام ليبوبلس 200&nbsp;مجم/مل</p><p dir="RTL">في حالة الإصابة بواحدة أو أكثر من الحالات المرضية التالية:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا بحساسية تجاه بروتين البيض أو السمك أو الفول السوداني أو فول الصويا أو أي من المكونات الأخرى لهذا الدواء (مدرجة في القسم&nbsp;6).</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع غير طبيعي في مستويات الدهون بالدم (فرط شديد في شحيمات الدم يتميز بفرط ثلاثي جليسريد الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>حالات مرضية تجعل الدم لا يتجلط بشكل صحيح (الاعتلال الخثري الحاد)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>اختلال تدفق الصفراء (ركود صفراوي داخل الكبد)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>فشل كبدي حاد (قصور كبدي حاد)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>فشل كلوي حاد (قصور كلوي حاد) دون الحصول على علاج بكلية صناعية (ترشيح الدم أو الغسيل الكلوي)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>انسداد الأوعية الدموية بالتخثرات الدموية أو الدهون (أحداث الانصمام الخثاري الحاد، الانصمام الدهني)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع مستوى المواد الحمضية بشكل غير طبيعي في الدم (الحماض)</p><p>&nbsp;</p><p dir="RTL">يجب ألا يتلقى المرضى بشكل عام تغذية صناعية من خلال التقطير الوريدي (التغذية بالحقن)</p><p dir="RTL">في حالة الإصابة بواحدة أو أكثر من الحالات المرضية التالية:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><strong>مشكلات بالدورة الدموية تمثل خطرًا على الحياة مثل تلك التي يمكن أن تحدث لك إذا كنت في حالة </strong>انهيار أو صدمة</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>مرحلة حادة من الأزمة القلبية (احتشاء عضلة القلب) أو السكتة الدماغية</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الأيض غير المستقر، مثل ما يحدث نتيجة داء السكري أو<strong> حالات العدوى التي تشمل الجسم بأكمله (الإنتان</strong> الشديد) أو الغيبوبة غير معروفة المصدر</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إمداد غير كاف من الأكسجين للأنسجة</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>اضطرابات في تكوين الملح بجسمك</em></p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص السوائل</em> أو وجود مياه زائدة في الجسم</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>وجود ماء في الرئتين (وذمة رئوية حادة)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل</em> القلب الحاد (قصور القلب غير المعاوض)</p><p>&nbsp;</p><p dir="RTL">تحذيرات واحتياطات</p><p>&nbsp;</p><p dir="RTL">تحدث إلى طبيبك قبل أخذ ليبوبلس 200&nbsp;مجم/مل.</p><p>&nbsp;</p><p dir="RTL">المراقبة</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>أثناء التسريب، ينبغي مراقبة كمية الدهون في دمك (ثلاثي الجليسريد في مصل الدم) من قِبل طبيبك. إذا ارتفعت قيم الدهون في دمك أكثر من اللازم، فقد يقوم طبيبك بخفض سرعة التسريب أو إيقافه.</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>أثناء تلقيك لهذا المحلول، ينبغي أن يقوم طبيبك بالتحقق من مستويات السوائل والأملاح في دمك والتوازن الحمضي القاعدي. ينبغي مراقبة وظائف الكبد والكلى وعملية تخثر الدم لديك، وينبغي أن يتم إجراء تحليل لحساب تعداد خلايا الدم.</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا ظهرت عليك العلامات الخاصة بأحد تفاعلات الحساسية &ndash; مثل الحمى أو الارتعاش، أو الطفح الجلدي أو مشكلات التنفس &ndash; أثناء تلقيك لهذا الدواء، ينبغي أن يقوم طبيبك بإيقاف التسريب فورًا.</p><p>&nbsp;</p><p dir="RTL">الإجراءات الإضافية</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>قبل تلقي هذا الدواء، سيقوم طبيبك بتصحيح أي اضطرابات موجودة في محتوى السوائل والأملاح في جسمك، بالإضافة إلى الاضطرابات الخاصة بالتوازن الحمضي القاعدي.</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>بالإضافة إلى ليبوبلس 200&nbsp;مجم/مل، يمكن أن تتلقى محلولًا من الكربوهيدرات ومحلولًا من الأحماض الأمينية لتجنب إصابتك بالحالات المرضية الأيضية التي فيها يصبح دمك حمضيًا (الحماض الأيضي).</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><strong>لكي تكون تغذيتك الوريدية مكتملة العناصر، يمكن أيضًا أن تتلقى محاليل الكربوهيدرات ومحاليل الأحماض الأمينية. </strong>وقد يقوم طاقم التمريض أيضًا باتخاذ الإجراءات اللازمة للتأكد من استيفاء المتطلبات الخاصة بنسبة السوائل والكهارل والفيتامينات والعناصر الشحيحة بجسمك.</p><p>&nbsp;</p><p dir="RTL">المرضى كبار السن</p><p dir="RTL">في بعض الحالات، قد يحدث خلل في قدرتك على معالجة الدهون بشكل صحيح. سيضع طبيبك في الاعتبار أن بعض هذه الحالات غالبًا ما ترتبط بتقدم العمر، مثل اختلال وظائف القلب أو الكلى.</p><p>&nbsp;</p><p dir="RTL">المرضى المصابون بمشكلات في القلب أو الكلى</p><p dir="RTL">إذا كنت مصابًا بمشكلات في القلب أو الكلى، فسيتوخى طبيبك الحذر بشكل خاص عند إعطائك هذا الدواء.</p><p>&nbsp;</p><p dir="RTL">المرضى المصابون باختلال أيض الدهون</p><p dir="RTL">في بعض الحالات، قد يحدث خلل في قدرتك على استخدام الدهون بشكل صحيح وقد تكون قيم الدهون بجسمك مرتفعة للغاية. ولذلك، من الضروري أن يكون طبيبك على علم بما يلي:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا<em> </em>بداء السكري</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا بالتهاب البنكرياس</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا<em> </em>باختلال في وظائف الكبد أو الكلى (قصور كلوي، اختلال وظائف الكبد)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت تعاني من انخفاض نشاط الغدة الدرقية (قصور الغدة الدرقية)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا بتسمم الدم (الإنتان)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>إذا كنت مصابًا بحالة مرضية قد يكون لديك فيها مزيج من 3 أو أكثر مما يلي: زيادة في الدهون حول البطن، وانخفاض في &quot;الكوليسترول الجيد&quot; (HDL‑C)، وزيادة في دهون الدم، وارتفاع ضغط الدم وزيادة في سكر الدم (متلازمة الأيض)</p><p dir="RTL">إذا كان هناك خلل في قدرتك على استخدام الدهون بشكل صحيح، ينبغي أن يقوم طبيبك بمراقبة مستويات الدهون في دمك (ثلاثي الجليسريد في مصل الدم) عن كثب.</p><p>&nbsp;</p><p dir="RTL">الأطفال والمراهقون</p><p dir="RTL">ينبغي أن يقوم الطبيب بمراقبة مستويات دهون الدم (ثلاثي الجليسريد في مصل الدم) ومستويات البيليروبين في الرضع المعرضين لخطر الإصابة بمرض اليرقان. وقد يصبح من الضروري أن يقوم طبيبك بتعديل مقدار الجرعات اليومية من الدهون.</p><p dir="RTL">أثناء التسريب، تنبغي حماية هذا المحلول من ضوء المعالجة الضوئية وهذا لتقليل تكوين المواد المحتمل أن تكون ضارة (الدهون الثلاثية وبيروكسيد الهيدروجين).</p><p>&nbsp;</p><p dir="RTL">الأدوية الأخرى وليبوبلس 200&nbsp;مجم/مل</p><p>&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتلقى في الوقت الحالي أو تلقيت مؤخرًا أو قد تتلقى أي أدوية أخرى.</p><p>&nbsp;</p><p dir="RTL">قد يتفاعل ليبوبلس 200&nbsp;مجم/مل مع بعض الأدوية الأخرى. أخبر طبيبك إذا كنت تتناول أو تتلقى أدوية معينة تمنع تخثر الدم غير المرغوب فيه، على وجه التحديد</p><p dir="RTL"><em>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>هيبارين</p><p dir="RTL"><em>●&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>منتجات الكومارين، على سبيل المثال وارفارين.</p><p dir="RTL">قد يكون ضروريًا أن تتحقق من تجلط الدم لديك من خلال أخذ عينات من الدم بانتظام.</p><p>&nbsp;</p><p dir="RTL">الحمل والرضاعة الطبيعية</p><p>&nbsp;</p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو كنتِ تعتقدين أنك قد تكونين حاملًا أو كنتِ تخططين للإنجاب، فاستشيري طبيبك قبل أخذ هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><em>الحمل</em></p><p dir="RTL">إذا كنتِ حاملًا، فستتلقين هذا الدواء فقط إذا رأى الطبيب أنه ضروري للغاية لتستردي عافيتك. لا توجد بيانات حول استخدام ليبوبلس 200&nbsp;مجم/مل للسيدات الحوامل.</p><p>&nbsp;</p><p dir="RTL"><em>الرضاعة الطبيعية</em></p><p dir="RTL">لا يوصى بالرضاعة الطبيعية للأمهات اللاتي تتم تغذيتهن وريديًا عن طريق الحقن.</p><p>&nbsp;</p><p dir="RTL">القيادة واستخدام الآلات</p><p>&nbsp;</p><p dir="RTL">ستتلقى هذا الدواء في بيئة خاضعة للمراقبة، أي مستشفى أو تحت أي نوع من الإشراف الطبي، والتي تمنع بدورها عادةً القيادة أو استخدام الآلات.</p><p>&nbsp;</p><p dir="RTL">يحتوي ليبوبلس 200&nbsp;مجم/مل على الصوديوم</p><p>&nbsp;</p><p dir="RTL">يحتوي ليبوبلس 200&nbsp;مجم/مل على 2.6&nbsp;مللي مول/لتر صوديوم. وهذا أمر ينبغي مراعاته من قبل المرضى الذين يتبعون نظامًا غذائيًا محدود الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الجرعة</p><p>&nbsp;</p><p dir="RTL">وسيقرر طبيبك الكمية التي تحتاجها من هذا الدواء والفترة التي يلزم خلالها العلاج بهذا الدواء.</p><p>&nbsp;</p><p dir="RTL">سيتم ضبط الجرعات اليومية وفقًا لاحتياجاتك وعمرك ووزن جسمك. يتم حساب الجرعات عادة على أساس &quot;جرام من الدهون لكل كجم من وزن الجسم&quot;. سيتم ايلاء الانتباه إلى أن معدلات التسريب والجرعات المعطاة لك صحيحة، حتى لا يتم تجاوز قدرة جسمك على استخدام الدهون التي يتم تسريبها.</p><p>&nbsp;</p><p dir="RTL">كيف يتم إعطاء ليبوبلس 200&nbsp;مجم/مل؟</p><p>&nbsp;</p><p dir="RTL">سيتم إعطاء ليبوبلس 200&nbsp;مجم/مل من خلال التقطير الوريدي كجزء من برامج التغذية. ولهذا الغرض، يتم إدخال أنبوب (قثطرة) إلى الوريد، يمكن من خلاله إعطاء مستحلب الدهون إما منفصلًا أو مع سوائل أخرى.</p><p>&nbsp;</p><p dir="RTL">إذا تلقيت كمية من ليبوبلس 200&nbsp;مجم/مل أكثر مما ينبغي</p><p>&nbsp;</p><p dir="RTL">إذا تلقيت جرعة زائدة من ليبوبلس 200&nbsp;مجم/مل، فقد تُصاب بارتفاع غير طبيعي في مستويات الدهون في دمك (فرط شحميات الدم)، أو قد يصبح دمك شديد الحمضية (الحماض الأيضي) أو قد تعاني مما يُدعى &quot;متلازمة تراكم الدهون&quot;. لمعرفة أعراض متلازمة تراكم الدهون، يُرجى الاطلاع على القسم&nbsp;4 &quot;الآثار الجانبية المحتملة&quot;.</p><p>&nbsp;</p><p dir="RTL">إذا تلقيت جرعة زائدة من ليبوبلس 200&nbsp;مجم/مل، فسيتم إيقاف التسريب على الفور. ولن يتم بدء التسريب من جديد قبل أن تتعافى تمامًا. وقد يكون من الضروري أن يقوم طبيبك بتعديل مقدار الجرعات اليومية من الدهون. وسيقرر طبيبك ما إذا كنت بحاجة لأي علاج إضافي.</p><p>&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا المنتج، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، غير أنها لا تصيب الجميع.</p><p>&nbsp;</p><p dir="RTL">الآثار الجانبية التالية قد تكون خطيرة. إذا أصبت بأي من الآثار الجانبية التالية، فاتصل بطبيبك على الفور، وسيتوقف عن إعطائك هذا الدواء:</p><p dir="RTL">نادرة للغاية: قد تصيب ما يصل إلى شخص واحد من بين 10000 شخص</p><p dir="RTL">-<em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تفاعلات حساسية، مثل التفاعلات الجلدية وضيق التنفس، وتورم الشفتين والفم والحلق وصعوبة التنفس</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>مشكلات التنفس (ضيق التنفس)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الجلد يميل إلى الزرقة (الزُراق)</p><p>&nbsp;</p><p dir="RTL">تتضمن الآثار الجانبية الأخرى</p><p dir="RTL">نادرة للغاية: قد تصيب ما يصل إلى شخص واحد من بين 10000 شخص</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>متلازمة تراكم الدهون (انظر قسم &quot;متلازمة تراكم الدهون&quot; أدناه)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>زيادة قابلية دمك للتخثر (فرط التخثر)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع غير طبيعي في مستويات الدهون بالدم (فرط شحميات الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع غير طبيعي في مستويات السكر بالدم (فرط سكر الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع مستويات المواد الحمضية في دمك (الحماض الأيضي)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>انخفاض أو ارتفاع ضغط الدم</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>النعاس</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الشعور بالغثيان، القيء، فقدان الشهية</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الصداع</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>احمرار الجلد</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>احمرار الجلد (الحمامي)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الحمى</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>التعرق</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الشعور بالبرد، القشعريرة</p><p>&nbsp;</p><p dir="RTL">نادرة: قد تصيب ما يصل إلى شخص واحد من كل 1000 شخص</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ألم في الظهر والعظم والصدر والمنطقة القطنية</p><p>&nbsp;</p><p dir="RTL">غير معروف: لا يمكن تقدير معدل التكرار من البيانات المتاحة</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>اختلال تدفق الصفراء (ركود صفراوي)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تعداد خلايا الدم البيضاء (قلة الكريات البيضاء)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض تعداد الصفائح الدموية (قلة الصفيحات)</p><p><strong>&nbsp;</strong></p><p dir="RTL">إذا أصبت بأي من هذه الآثار الجانبية، فسيتم إيقاف التسريب.</p><p><strong>&nbsp;</strong></p><p dir="RTL">متلازمة تراكم الدهون:</p><p><em>&nbsp;</em></p><p dir="RTL">يمكن أن تعاني من &quot;متلازمة تراكم الدهون&quot; إذا تلقيت جرعة زائدة من ليبوبلس 200&nbsp;مجم/مل أو إذا كان جسمك يعاني من مشكلات خاصة باستخدام الدهون. قد تتأثر قدرة جسمك على معالجة الدهون عند حدوث تغيير مفاجئ في حالتك (نتيجة لوجود مشاكل في الكلى أو الإصابة بعدوى). عادةً ما يمكن التخلص من الأعراض في حالة إيقاف التسريب. تتميز متلازمة تراكم الدهون بالأعراض التالية:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ارتفاع مستويات الدهون في الدم (فرط شحميات الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الحمى</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>ترسب الدهون في الكبد أو في أعضاء أخرى (ارتشاح الدهون)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>زيادة حجم الكبد (تضخم الكبد)، الذي قد يكون مصحوبًا أحيانًا باليرقان</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>زيادة حجم الطحال (تضخم الطحال)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>انخفاض تعداد خلايا الدم الحمراء (فقر الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>انخفاض تعداد خلايا الدم البيضاء (قلة الكريات البيضاء)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>انخفاض تعداد الصفائح الدموية (قلة الصفيحات)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>اضطراب تخثر الدم (تجلط الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تكسر خلايا الدم (انحلال الدم)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>زيادة خلايا الدم الحمراء غير الناضجة (كثرة الشبكيات)</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>نتائج غير طبيعية لاختبارات وظائف الكبد</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>فقدان الوعي (غيبوبة)</p><p>&nbsp;</p><p dir="RTL">الإبلاغ عن الآثار الجانبية</p><p dir="RTL">إذا عانيت من أي آثار جانبية، فتحدث إلى طبيبك أو الصيدلي. يشمل هذا أي آثار جانبية محتملة غير مذكورة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p>&nbsp;</p><p dir="RTL"><strong>معلومات الاتصال</strong></p><p dir="RTL"><strong>المركز الوطني للتيقظ والسلامة الدوائية &ndash; الهيئة العامة للغذاء والدواء</strong></p><p dir="RTL"><strong>المملكة العربية السعودية</strong></p><p dir="RTL"><strong>فاكس: 2057662 96611+</strong></p><p dir="RTL"><strong>بريد إلكتروني: npc.drug@sfda.gov.sa</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p>&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء بعد مرور تاريخ انتهاء الصلاحية المدون على الملصق والعلبة الكرتونية الخارجية. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من ذلك الشهر.</p><p>&nbsp;</p><p dir="RTL">ينبغي استخدام ليبوبلس 200&nbsp;مجم/مل مباشرةً بعد فتحه لأول مرة.</p><p>&nbsp;</p><p dir="RTL">لا يحفظ الدواء في درجة حرارة أعلى من 25&nbsp;درجة مئوية.</p><p dir="RTL">احفظ الحاوية في العلبة الكرتونية الخارجية لحمايتها من الضوء.</p><p dir="RTL">لا تقم بتجميد الدواء. يجب التخلص من المنتجات التي تجمدت.</p><p>&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت:</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>نقاط زيت كبيرة في المستحلب أو طبقتين منفصلتين من السوائل</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تغير اللون</p><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>تلف الحاوية أو عبوة الإغلاق.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">محتويات ليبوبلس 200&nbsp;مجم/مل</p><p>&nbsp;</p><p dir="RTL">- المواد الفعالة في 1000&nbsp;مل من ليبوبلس 200&nbsp;مجم/مل هي:</p><p dir="RTL">ثلاثي الجليسريد متوسط السلسلة&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100.0&nbsp;جم</p><p dir="RTL">زيت فول الصويا المُكرر&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 80.0&nbsp;جم</p><p dir="RTL">حمض أوميجا 3 ثلاثي الجليسريد&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 20.0&nbsp;جم</p><p>&nbsp;</p><p dir="RTL">هذا يعطي المحتوى التالي من الأحماض الدهنية الأساسية لكل لتر:</p><p dir="RTL">حمض اللينولييك (أوميجا 6)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38.4‑46.4&nbsp;جم</p><p dir="RTL">حمض ألفا-اللينولينيك (أوميجا 3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4.0‑8.8&nbsp;جم</p><p dir="RTL">حمض الإيكوسابنتاينويك و<br />حمض الدوكوساهكساينويك (أوميجا 3)&nbsp;&nbsp;&nbsp; 8.6‑17.2&nbsp;جم</p><p>&nbsp;</p><p dir="RTL">200&nbsp;مجم/مل (20%) يماثل إجمالي محتوى ثلاثي الجليسريد.</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL">7990 (191)</p></td><td><p dir="RTL">الطاقة [كيلو جول/لتر(كيلو كالوري/لتر)]</p></td></tr><tr><td><p dir="RTL">410</p></td><td><p dir="RTL">الأسمولية [ملي أسمول/كجم]، تقريبًا</p></td></tr><tr><td><p dir="RTL">&lt; 0.5</p></td><td><p dir="RTL">درجة الحموضة أو القلوية (المعايرة حتى الرقم الهيدروجيني pH&nbsp;7.4) [هيدروكسيد صوديوم أو كلوريد الهيدروجين ميلي مول/لتر]</p></td></tr><tr><td><p dir="RTL">6.5‑8.5</p></td><td><p dir="RTL">الرقم الهيدروجيني pH</p></td></tr></tbody></table><p>&nbsp;</p><p dir="RTL">- المكونات الأخرى هي جليسيرول، وليسيثين البيض، وأسيتات ألفا توكوفيرول راسيمي، وبالميتات الأسكوربيل، وأوليَّات الصوديوم، وهيدروكسيد الصوديوم (لضبط درجة الحموضة) وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ليبوبلس 200&nbsp;مجم/مل هو مستحلب مائي زيتي معقم لونه أبيض حليبي للتسريب (للإعطاء بالتقطير الوريدي).</p><p>&nbsp;</p><p dir="RTL">يتم توفيره في قوارير زجاجية مغطاة بسدادات مطاطية، أحجام العبوات:</p><p dir="RTL">10&nbsp;&times;&nbsp;100&nbsp;مل، 1&nbsp;&times;&nbsp;250&nbsp;مل، 10&nbsp;&times;&nbsp;250&nbsp;مل، 1&nbsp;&times;&nbsp;500 مل، 10&nbsp;&times;&nbsp;500&nbsp;مل، 1&nbsp;&times;&nbsp;1000&nbsp;مل، 6&nbsp;&times;&nbsp;1000&nbsp;مل</p><p>&nbsp;</p><p dir="RTL">ليست كل أحجام العبوات يمكن أن تُطرح في الأسواق.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">Braun Melsungen AG .B&nbsp;</p><p dir="RTL">Carl-Braun-Stra&szlig;e 1</p><p dir="RTL">34212 Melsungen, Germany</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>العنوان البريدي</em></p><p dir="RTL">34209 Melsungen, Germany</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2016-03-10.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Lipoplus 200 mg/ml emulsion for infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1000 ml of emulsion contains:

Medium-chain triglycerides 100.0 g
Soya-bean oil, refined 80.0 g
Omega-3-acid triglycerides 20.0 g

Content of triglycerides 200 mg/ml (20%)

Content of essential fatty acids
Linoleic acid (omega-6) 38.4 - 46.4 g/l
Alpha-linolenic acid (omega-3) 4.0 - 8.8 g/l
Eicosapentaenoic acid and
docosahexaenoic acid (omega-3) 8.6 - 17.2 g/l

Excipient(s) with known effect:
1000 ml emulsion contains 2.6 mmol sodium (as sodium hydroxide and sodium oleate).

For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Emulsion for infusion

Milky-white oil-in-water emulsion

Energy 7990 kJ/l . 1910 kcal/l
Osmolality approximately 410 mOsm/kg
Acidity or alkalinity (titration to pH 7.4) less than 0.5 mmol NaOH/l or HCl/l
pH 6.5 - 8.5
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Supply of energy, including a readily utilisable lipid component (medium-chain triglycerides) and essential<br />omega-6 fatty acids and omega-3 fatty acids, as part of parenteral nutrition when oral or enteral nutrition is<br />impossible, insufficient or contraindicated.</p><p>Lipoplus is indicated in adults, preterm and term neonates, infants and toddlers, children and adolescents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />The dosage has to be adapted to the patients&nbsp;individual requirements.</p><p>Maximum daily doses should only be administered after stepwise increase with careful monitoring of the tolerance of the infusions.</p><p>The utilisation of intravenous lipids depends on e.g. the severity of underlying disease, body weight, gestational and postnatal age and specific body functions.</p><p>Depending on energy requirements, the following daily doses are recommended:</p><p>Adults<br />The usual dose is 0.7 to 1.5 g lipids/kg body weight (b.w.) per day. A maximum dose of 2.0 g lipids/kg b.w./d,<br />for instance when energy requirements are high or fat utilisation is increased (e.g. oncology patients), should not be exceeded For long-term home parenteral nutrition treatment (&gt; 6 months) and in patients with short<br />bowel syndrome the provision of intravenous lipids should not exceed 1.0 g/kg b.w./d.<br />For a patient weighing 70 kg a daily dose of 2.0 g/kg b.w./d corresponds to a maximum daily dose of 700 ml Lipoplus.</p><p>Paediatric population<br />A gradual increase of lipid intake in increments of 0.5 � 1.0 g/kg b.w./d may be beneficial regarding the possibility to monitor the increase of the plasma triglyceride level and prevent hyperlipidaemia.</p><p>Preterm newborn infants, term newborn infants, infants and toddlers<br />It is recommended not to exceed a daily dose of 2.0 � 3.0 g/kg b.w./d of lipids.</p><p>In preterm newborn infants, term newborn infants, infants and toddlers, the daily dose of lipids should be<br />infused continuously over about 24 hours.</p><p>Children and adolescents<br />It is recommended not to exceed a daily lipid dose of 2.0 � 3.0 g/kg b.w./d.</p><p>Elderly patients<br />Basically the same dosage as for adults applies, but caution should be exercised in patients suffering from<br />further diseases like cardiac insufficiency or renal insufficiency that may frequently be associated with advanced age.</p><p>Patients with diabetes mellitus, impaired cardiac or renal function<br />See section 4.4.</p><p>Patients with hepatic impairment<br />See section 4.4 (�Patients with impaired lipid metabolism�).</p><p>Infusion rate<br />The infusion should be administered at the lowest possible infusion rate. During the first 15 minutes the infusion rate should only be 50% of the maximum infusion rate to be used.<br />The patient should be monitored closely for the occurrence of adverse reactions.</p><p>Maximum infusion rate<br />Adults<br />Up to 0.15 g/kg b.w./h lipids.<br />For a patient weighing 70 kg this corresponds to a maximum infusion rate of 52.5 ml per hour Lipoplus. The amount of lipids administered then is 10.5 g per hour.</p><p>Preterm newborn infants, term newborn infants, infants and toddlers<br />Up to 0.15 g/kg b.w./h lipids.</p><p>Children and adolescents<br />Up to 0.15 g/kg b.w./h lipids.</p><p>Method of administration<br />Intravenous use.<br />Lipid emulsions are suitable for peripheral venous administration and can also be administered separately via peripheral veins as part of total parenteral nutrition.<br />The Y- or the bypass connector should be placed as close to the patient as possible if lipid emulsions are coadministered<br />with amino acid and carbohydrate solutions. For further instructions on handling of the medicinal product before administration, see section 6.6.</p><p>Duration of treatment<br />As clinical experience with long-term use of Lipoplus is limited, it should normally not be administered for longer than one week. If parenteral nutrition with lipid emulsions is further indicated, Lipoplus can be administered over longer periods provided appropriate monitoring is employed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                . Hypersensitivity to the active substances, to egg, fish, peanut or soya protein or to any of the excipients
listed in section 6.1
. Severe hyperlipidaemia characterized by hypertriglyceridaemia (. 1000 mg/dl or 11.4 mmol/l)
. Severe coagulopathy
. Intrahepatic cholestasis
. Severe hepatic insufficiency
. Severe renal insufficiency in absence of renal replacement therapy
. Acute thromboembolic events, fat embolism
. Acidosis

General contraindications to parenteral nutrition include:
� Unstable circulatory status with vital threat (states of collapse and shock)
� Acute phases of cardiac infarction or stroke
� Unstable metabolic conditions (e.g. decompensated diabetes mellitus, severe sepsis, coma of unknown
origin)
� Inadequate cellular oxygen supply
� Disturbances of the electrolyte and fluid balance
� Acute pulmonary oedema
� Decompensated cardiac insufficiency
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The serum triglyceride concentration should be monitored when infusing Lipoplus.</p><p>In patients with suspected disorders of lipid metabolism, fasting hyperlipidaemia should be ruled out before the start of the infusion.</p><p>Depending on the patient&#39;s metabolic condition, occasional hypertriglyceridaemia may occur. If the plasma triglyceride concentration exceeds 4.6 mmol/l (400 mg/dl) in adults during administration of lipids it is<br />recommended to reduce the infusion rate. The infusion must be interrupted if the plasma triglyceride<br />concentration exceeds 11.4 mmol/l (1000 mg/dl), as these levels have been associated with an increased risk for<br />acute pancreatitis.</p><p>Disturbances of the fluid, electrolyte or acid-base balance must be corrected before the start of infusion.</p><p>Refeeding or repletion of malnourished or depleted patients may cause hypokalaemia, hypophosphataemia and<br />hypomagnesaemia. Adequate supplementation of electrolytes according to deviations from normal values is<br />necessary.</p><p>Controls of the serum electrolytes, the water balance, the acid-base balance, and of blood cell counts,<br />coagulation status, hepatic and renal function are necessary.</p><p>Any sign or symptom of anaphylactic reaction (such as fever, shivering, rash or dyspnoea) should lead to<br />immediate interruption of the infusion.</p><p>Energy supply with lipid emulsions only could cause metabolic acidosis. It is therefore recommended to infuse<br />an adequate quantity of intravenous carbohydrates or carbohydrate-containing amino acid solutions along with the<br />fat emulsion.</p><p>For patients requiring complete parenteral nutrition, complementary carbohydrate, amino acid, electrolyte,<br />vitamin, and trace element supplements are required. Also, an adequate total fluid intake has to be ensured.</p><p>Impaired capacity to eliminate triglycerides can lead to �fat overload syndrome� which may be caused by<br />overdose (see section 4.8 and 4.9.).</p><p>Mixing with incompatible substances might lead to breaking of the emulsion or to precipitation of particles (see sections 6.2 and 6.6), both resulting in a high risk of embolism.</p><p>There is as yet only limited experience of the use of Lipoplus for periods longer than seven days.</p><p>As with all intravenous solutions, especially for parenteral nutrition, strict aseptic precautions are necessary for the infusion of Lipoplus.<br /><br />Patients with diabetes mellitus, impaired cardiac or renal function<br />Like all large-volume infusion solutions, Lipoplus should be administered with caution to patients with impaired cardiac or renal function.<br />There is only limited experience of its use in patients with diabetes mellitus or renal failure.</p><p>Patients with impaired lipid metabolism<br />Lipoplus should be administered cautiously to patients with disturbances of lipid metabolism with increased serum triglycerides, e.g. renal insufficiency, diabetes mellitus, pancreatitis, impaired hepatic function,<br />hypothyroidism (with hypertriglyceridaemia), sepsis, and metabolic syndrome. If Lipoplus is given to patients with these conditions, more frequent monitoring of serum triglycerides is necessary to assure triglyceride elimination and stable triglyceride levels below 11.4 mmol/l (1000 mg/dl).<br />In combined hyperlipidaemias and in metabolic syndrome, triglyceride levels react to glucose, lipids and overnutrition. Adjust dose accordingly. Assess and monitor other lipid and glucose sources, and drugs interfering with their metabolism.<br />The presence of hypertriglyceridaemia 12 hours after the administration of lipids also indicates disturbance of lipid metabolism.</p><p>Paediatric population<br />Free fatty acids (FFA) compete with bilirubin for albumin binding sites. Especially very premature infants may be at increased risk of hyperbilirubinaemia due to high levels of FFA released from triglycerides resulting in a high FFA/albumin ratio. In parenterally fed infants at risk of hyperbilirubinaemia, serum triglyceride and bilirubin levels should be monitored and lipid infusion rate be adjusted if deemed necessary.<br />During infusion Lipoplus should be protected from phototherapy light to decrease the formation of potentially harmful triglyceride hydroperoxides.<br />The serum triglyceride concentration should be regularly monitored during the infusion of Lipoplus (especially in very small preterm infants), especially if there is an increased risk of hyperlipidaemia (e.g. in situations of stress or infection). A stepwise increase of the daily dose may be advisable.<br />Depending on the patient&#39;s metabolic condition, occasional hypertriglyceridaemia may occur. In infants dose reduction should be considered if the plasma triglyceride concentration during infusion exceeds 2.8 mmol/l (250 mg/dl). In older children and adolescents dose reduction should be considered if the plasma triglyceride concentration during infusion exceeds 4.6 mmol/l (400 mg/dl).</p><p>Special warnings/precautions regarding excipients<br />Lipoplus contains 2.6 mmol/l of sodium. This should be taken into consideration for patients on a controlled sodium diet.</p><p>Interference with laboratory tests<br />Lipids may interfere with certain laboratory tests (such as bilirubin, lactate dehydrogenase, oxygen saturation)<br />when the blood sample is taken before the lipids have been eliminated from the bloodstream, this may take 4 to<br />6 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.</p><p>Heparin given in clinical doses causes a transient release of lipoprotein lipase into the bloodstream. This may initially lead to increased plasma lipolysis, followed by a transient decrease in triglyceride clearance.</p><p>Soya-bean oil has a natural content of vitamin K1. This may interfere with the therapeutic effect of coumarin derivatives, which should be closely monitored in patients treated with such drugs.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are no or limited amount of data from the use of Lipoplus in pregnant women. Animal studies undertaken with a lipid emulsion containing twice the amount of omega-3 acid triglycerides and a correspondingly smaller amount of omega-6-acid triglycerides as compared to Lipoplus do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see section 5.3).<br />Parenteral nutrition may become necessary during pregnancy. Lipoplus should only be administered to pregnant women after careful benefit-risk consideration.</p><p>Breastfeeding<br />Components/metabolites of Lipoplus are excreted in human milk, but at therapeutic doses of Lipoplus no effects on the breastfed newborns/infants are anticipated. In general, breastfeeding is not recommended to mothers on parenteral nutrition.</p><p>Fertility<br />No data from the use of Lipoplus available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following listing includes a number of systemic adverse reactions that may be associated with the use of<br />Lipoplus. Under the conditions of correct use, in terms of dosing, monitoring, observation of safety restrictions and instructions, most of them are very rare (&lt; 1/10,000).</p><p>Undesirable effects are listed according to their frequencies as follows:<br />Very common (&gt;/=&nbsp;1/10)<br />Common (&gt;/= 1/100 to &lt; 1/10)<br />Uncommon (&gt;/=&nbsp;1/1,000 to &lt; 1/100)<br />Rare (&gt;/=&nbsp;1/10,000 to &lt; 1/1,000)<br />Very rare (&lt; 1/10,000)<br />Not known (cannot be estimated from the available data)</p><p>Blood and lymphatic system disorders<br />Very rare: Hypercoagulation<br />Not known: Leucopenia, thrombocytopenia</p><p>Immune system disorders<br />Very rare: Allergic reactions (e.g. anaphylactic reactions, dermal eruptions, laryngeal, oral and facial<br />oedema)</p><p>Metabolism and nutrition disorders<br />Very rare: Hyperlipidaemia, metabolic acidosis<br />The frequency of these adverse reactions is dose-dependent and may be higher under conditions<br />of absolute or relative overdose.<br />Very rare: Hyperglycaemia</p><p>Nervous system disorders<br />Very rare: Headache, drowsiness</p><p>Vascular disorders<br />Very rare: Hypertension or hypotension, flush</p><p>Respiratory, thoracic and mediastinal disorders<br />Very rare: Dyspnoea, cyanosis</p><p>Gastrointestinal disorders<br />Very rare: Nausea, vomiting, loss of appetite</p><p>Skin and subcutaneous tissue disorders<br />Very rare: Erythema, sweating</p><p>Hepatobiliary disorders<br />Not known: Cholestasis</p><p>Musculoskeletal and connective tissue disorders<br />Rare: Back, bones, chest and lumbar region pain</p><p>General disorders and administration site conditions<br />Very rare: Elevated body temperature, feeling cold, chills, fat overload syndrome (see below).</p><p>Should adverse reactions occur, the infusion must be stopped.<br />Should the triglyceride level rise to above 11.4 mmol/l (1000 mg/dl) during infusion, the infusion must be stopped. With levels above 4.6 mmol/l (400 mg/dl), the infusion may be continued at a reduced dosage (see section 4.4).</p><p>If the infusion is restarted, the patient should be carefully monitored, especially at the beginning, and serum triglycerides should be determined at short intervals.</p><p>Information on particular undesirable effects<br />Nausea, vomiting and lack of appetite are symptoms often related to conditions for which parenteral nutrition is indicated, and may be associated with parenteral nutrition at the same time.</p><p>Fat overload syndrome<br />Impaired capacity to eliminate triglycerides can lead to &quot;fat overload syndrome&quot;&nbsp;which may be caused by overdose. Possible signs of metabolic overload must be observed. The cause may be genetic (individually<br />different metabolism) or the fat metabolism may be affected by ongoing or previous diseases. This syndrome may also appear during severe hypertriglyceridaemia, even at the recommended infusion rate, and in<br />association with a sudden change in the patient&#39;s clinical condition, such as renal function impairment or infection. The fat overload syndrome is characterised by hyperlipidaemia, fever, fat infiltration, hepatomegaly<br />with or without icterus, splenomegaly, anaemia, leucopenia, thrombocytopenia, coagulation disorder, haemolysis and reticulocytosis, abnormal liver function tests and coma. The symptoms are usually reversible if the infusion of the fat emulsion is discontinued.<br />Should signs of a fat overload syndrome occur, the infusion of Lipoplus must be discontinued immediately.`</p><p><strong>Reporting of side effects</strong></p><p><strong>National Pharmacovigilance &amp; Drug Safety Center (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc</strong></p><p><strong>By reporting side effects you can help provide more information on<br />the safety of this medicine.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Hyperlipidaemia, metabolic acidosis.<br />Also, a fat overload syndrome may occur. See section 4.8.</p><p>Treatment<br />Immediate cessation of infusion is indicated for overdose. Other therapeutic measures will depend on a patient&#39;s specific symptoms and their severity. When the infusion is recommenced after symptoms have declined, it is recommended that the infusion rate should be raised gradually with monitoring at frequent intervals..</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Solutions for parenteral nutrition, fat emulsions<br />ATC code: B05B A02</p><p>Lipoplus is intended to provide energy and polyunsaturated (&quot;essential&quot;) omega-6 and omega-3 fatty acids as part of parenteral nutrition. For this purpose Lipoplus contains medium-chain triglycerides, soya-bean oil (longchain triglycerides, mainly omega-6), and triglycerides containing omega-3 fatty acids (long-chain triglycerides).</p><p>Medium-chain triglycerides are more rapidly hydrolysed, faster eliminated from the circulation, and more completely oxidised than long-chain triglycerides. Hence they are a preferred energy substrate, particularly when there are disturbances of the degradation and/or utilisation of long-chain triglycerides, e.g. in case of lipoprotein lipase deficiency, deficiency of lipoprotein lipase cofactors, carnitine deficit and impairment of the carnitine-dependent transport system.</p><p>In detail, long-chain omega-3 polyunsaturated fatty acids are precursors for anti-inflammatory eicosanoids.<br />They reduce pro-inflammatory cytokine production from arachidonic acid and increasing anti-inflammatory cytokine production from eicosapentaenoic acid and docosahexaenoic acid. This may be of benefit in patients at risk of developing a hyperinflammatory state and sepsis.</p><p>Only the long-chain omega-6 and omega-3 triglycerides supply polyunsaturated fatty acids, so these are primarily included for prophylaxis and therapy of essential fatty acid deficiency and, only secondarily, as a<br />source of energy. Lipoplus supplies essential omega-6 fatty acids, mainly in the form of linoleic acid, and omega-3 fatty acids in the form of alpha-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid.</p><p>Phosphatides, besides their function as emulsifier for the triglycerides, are components of the cell membranes and guarantee their fluidity and biological functions.</p><p>Glycerol, which has been added with the aim to render the emulsion isotonic to blood, is a physiological intermediate in the metabolism of glucose and lipids: it is metabolised to yield energy or is utilised for the synthesis of glucose, glycogen and triglycerides.</p><p>The ratio of omega-6/omega-3 fatty acids in Lipoplus is approximately 2.5:1.</p><p>Safety pharmacological investigations have not revealed any specific effects other than the above-mentioned nutritive effects, which are the same as when the particular substrates were administered orally.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Distribution<br />The dose, rate of infusion, metabolic state and individual factors concerning the patient (level of fasting) are the most relevant factors determining the maximum serum triglyceride concentration.<br />Placental tissue preferentially takes up long-chain polyunsaturated fatty acids from the maternal circulation and regulates their transfer to the foetal circulation.</p><p>Biotransformation<br />After infusion, triglycerides are hydrolysed to glycerol and fatty acids. Both are incorporated in physiological<br />pathways for energy production, synthesis of biological active molecules, gluconeogenesis and resynthesis of<br />lipids.</p><p>Elimination<br />Both the triglycerides of soya-bean oil and medium-chain triglycerides are completely metabolised to CO2 and H2O. Omega-3 acid triglycerides are either completely oxidised to CO2 and water or incorporated in cell membranes and then metabolised to eicosanoids and cytokines. Up to 30% to 70% of the infused lipids are oxidised within 24 h, whereas the elimination rate largely depends on nutritional state, hormonal balance,<br />simultaneous infusion of glucose solution, etc. Renal excretion does virtually not occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical studies including safety pharmacology, reproductive and developmental toxicity studies with a lipid emulsion containing twice the amount of omega-3 acid triglycerides present in the final product and a<br />correspondingly smaller amount of long chain omega-6 triglycerides revealed no effects other than those expected following administration of high doses of lipids. In a rabbit reproductive toxicity study no evidence of<br />embryotoxicity or teratogenicity was seen at a dose of 2 g lipid/kg body weight per day for 12 days.</p><p>Phytoestrogens such as <s>B</s>-sitosterol can be found in various vegetable oils, especially in soya-bean oil.<br />Impairment of fertility was observed in rats and rabbits after subcutaneous and intravaginal administration of B-sitosterol.<br />After administration of pure B-sitosterol a decrease of the testicular weight and a reduction of the sperm concentration in male rats and a lowered pregnancy rate in female rabbits were recorded. However,<br />according to the current state of knowledge the observed effects in animals do not seem to have relevance for clinical use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Egg lecithin<br />Glycerol<br />Sodium oleateion</p><p>Ascorbyl palmitate<br />all-rac-a-Tocopherol<br />Sodium hydroxide (for pH adjustment)<br />Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened
2 years

After first opening the container
After first opening the medicinal product should be used immediately.

After admixture of compatible additives
From a microbiological point of view, the product should be used immediately after admixture of additives. If
not used immediately after admixture of additives, in-use storage times and conditions prior to use are the
responsibility of the user
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25 C.<br />Do not freeze. If accidentally frozen, discard the container.<br />Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glass bottle (type II glass) with a halogen butyl rubber stopper.</p><p>Pack sizes:<br />100 ml, available in packs of 10 x 100 ml<br />250 ml, available in packs of 1 x 250 ml and 10 x 250 ml<br />500 ml, available in packs of 1 x 500 ml and 10 x 500 ml<br />1000 ml, available in packs of 1 x 1000 ml and 6 x 1000 ml</p><p>Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>If filters are used, these must be permeable to lipids.</p><p>Before infusing a lipid emulsion together with other solutions via a Y connector or bypass set, the compatibility<br />of these fluids should be checked, especially when co-administering carrier solutions to which drugs have been be marketed.</p><p>added. Particular caution should be exercised when co-infusing solutions that contain divalent cations (such as<br />calcium or magnesium).</p><p>Shake gently prior to use.</p><p>The emulsion has to be brought to room temperature unaided prior to infusion, i.e., the product should not be<br />put in a heating device (such as oven or microwave).</p><p>For single use only. Container and unused residues must be discarded after use. Do not reconnect partially used<br />containers.</p><p>Only use containers that are undamaged and in which the emulsion is homogeneous and milky-white. Inspect<br />the emulsion visually for phase separation prior to administration (oil drops, oil layer).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                B. Braun Melsungen AG
Carl-Braun-Str 1
34212 Melsungen
Germany
Postal address
B. Braun Melsungen AG
34209 Melsungen
Germany
Phone: +49-5661-71-0
Fax: -+49-5661-71-4567
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                03/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>